Scale -


  • Revenue is 6.9 Rs Cr; Annual Decline is -18 %; Continuous Decline over 3 years
  • Ebitda is -1.75 Rs Cr; Annual Decline is -17400 %; Continuous Decline over 3 years; in Bottom Quartile
  • PBT is -0.4 Rs Cr; Annual Decline is -239 %; in Bottom Quartile
  • PAT is -2.37 Rs Cr; Annual Decline is -239 %; Continuous Decline over 3 years; in Bottom Quartile
  • Quarterly Ebitda is -0.35 Rs Cr; in Bottom Quartile

Profitability -


  • PBDIT Margin is -25.3 %; Annual Decline is -20983 %; Continuous Decline over 3 years; in Bottom Quartile
  • PAT Margin is -34.29 %; Annual Decline is -309 %; Continuous Decline over 3 years; in Bottom Quartile
  • Quarterly Ebitda Margin is -19 %; in Bottom Quartile
  • Quarterly Profit margin is -21 %; in Bottom Quartile

Return -


  • ROCE is -16.62 %; Annual Decline is -547 %; Continuous Decline over 3 years; in Bottom Quartile
  • ROA is -6.57 %; Annual Decline is -237 %; Continuous Decline over 3 years; in Bottom Quartile
  • ROE is -23.35 %; Annual Decline is -193 %; Continuous Decline over 3 years; in Bottom Quartile

Efficiency -


  • Operating cash flow is -0.59 Rs Cr; Annual Decline is -34 %
  • Current Ratio is 1.38; in Bottom Quartile
  • Quick Ratio is 1.38; in Bottom Quartile

Solvancy -


  • Contingent Liabilities is 0.07 Rs Cr; Annual Decline is -73 %; 5 Year CAGR is -21 %
  • Total Debt is 5.59 Rs Cr; Continuous Growth over 3 years
  • Debt/Equity is 0.55; in Top Quartile
  • Long term Debt is 0 Rs Cr; in Top Quartile

Quality -


  • Other Expenses/Total Expenses is 33 %; Annual Decline is -46 %
  • Operating cashflow/ebitda is 34 %; Annual Decline is -99 %; 5 Year CAGR is -50 %
  • Operating cashflow/PAT is 25 %; Annual Decline is -60 %; 5 Year CAGR is -71 %
  • Exceptional Items/PBT is 0 %; in Top Quartile
  • Change in Inventories/Total Expenses is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Vertex Securities Q2FY27 Results: Net loss widens 44% YoY to ?50 lakh
Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.21% on Oct 1: What Investors Need To Know